Summary
[Essence Pharma: Ritonavir intermediates will be mainly supplied to Desano in 2021]Essence Pharma stated on the interactive platform that the ritonavir intermediates produced by the company in 2021 are mainly supplied to Desano, which has not been signed since January 2022 Large orders related to ritonavir intermediates. (First Finance and Economics)
Essence PharmaAccording to the interactive platform, the ritonavir intermediates produced by the company in 2021 are mainly supplied to Desano, and no large orders related to ritonavir intermediates have been signed since January 2022.
(Article source: First Finance and Economics)
Article source: First Financial
Responsible editor: 83
Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.
report
Scan the QR code to follow
Oriental Fortune official website WeChat